Dr Obinna Ubah [Elasmogen Limited]

Host: Dr Sabelo Hadebe

Dr Ubah Programme lead in autoimmune inflammation diseases drug discovery at Elasmogen Limited, a
University of Aberdeen spinout biotech company. His research interest broadly encompasses biologics
drug discovery and drug development for chronic diseases such as autoimmune inflammation diseases and cancers. He holds a BPharm (University of Benin, Nigeria) MSc with distinction and PhD funded by Scottish Universities Life Sciences Alliance (SULSA)/Merck Sharp & Dohme (MSD) (all University of Aberdeen, Scotland) and PGCert in IP Law from the University of South Africa (UNISA). He is also a Fellow of the UK Higher Education Academy and holds a lectureship position in the School of Medicine and Medical Sciences at the University of Aberdeen. Obinna is the president of a Scottish registered foundation (FISEA) focused on bridging the life sciences knowledge gape between the UK and Africa. In October 2021, he was awarded the prestigious UKRI Future Leaders Fellowship with a 2M grant to continue advancing his cutting-edge drug discovery research and leadership development